Biotech

All Articles

Amgen files 1st phase 3 win for $400M dermatitis drug

.Amgen has shared (PDF) the initial stage 3 records on its $400 thousand eczema drug, connecting the...

Biogen, UCB record phase 3 lupus win after neglecting earlier trial

.Biogen as well as UCB's depend developing into period 3 on the back of a failed research hopes to h...

Aptadir wishes brand new RNA inhibitors can easily reverse challenging cancers cells

.Italian biotech Aptadir Rehabs has introduced along with the promise that its pipeline of preclinic...

Wave surfs DMD results to regulators' doors, sending out stockpile

.Wave Life Sciences has actually met its own goal in a Duchenne muscular dystrophy (DMD) study, inst...

Sanofi tweezes brand-new CSO coming from in-stealth biotech

.After a handful of years in biotech, Mike Quigley, Ph.D., is coming back to the pharma fold, taking...

Achilles trickles tissue therapy course, supports for unemployments after missing out on 'commercial practicality' targets

.Achilles Therapies has torn up its approach. The English biotech is actually quiting working on its...

Aligos proclaims stage 2 MASH succeed, reducing liver body fat around 46%

.Aligos Therapeutics is actually proclaiming a midstage gain in metabolic-dysfunction affiliated ste...

Basilea credit ratings $268M BARDA backing for antifungals, antibiotics

.Basilea Pharmaceutica's work creating brand new antifungals has acquired a significant boost coming...

Capricor offers Europe liberties to late-stage DMD treatment for $35M

.Having already gathered up the united state civil liberties to Capricor Therapies' late-stage Duche...

FDA scraps adcomm for Applied's unusual health condition drug

.After dismissing the choice date for Applied Therapies' metabolic condition medicine govorestat, th...